medimmune.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | AstraZeneca - Research-Based BioPharmaceutical |
| Description | What science can AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 165.160.15.20 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
medimmune.com Valuation
|
US$1,470
Last updated: 2023-05-14 10:08:19
medimmune.com has Semrush global rank of 0. medimmune.com has an estimated worth of US$ 1,470, based on its estimated Ads revenue. medimmune.com receives approximately 169 unique visitors each day. Its web server is located in United States, with IP address 165.160.15.20. According to SiteAdvisor, medimmune.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,470 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$40 |
| Yearly Ads Revenue | US$488 |
| Daily Unique Visitors | 11 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| medimmune.com. | A | 14399 | IP: 165.160.15.20 |
| medimmune.com. | A | 14399 | IP: 165.160.13.20 |
| medimmune.com. | NS | 14400 | NS Record: dns2.cscdns.net. |
| medimmune.com. | NS | 14400 | NS Record: dns1.cscdns.net. |
| medimmune.com. | MX | 300 | MX Record: 10 de-smtp-inbound-1.mimecast.com. |
| medimmune.com. | MX | 300 | MX Record: 10 de-smtp-inbound-2.mimecast.com. |
| medimmune.com. | TXT | 14400 | TXT Record: google-site-verification=bNB6ohWBxTlWYsb5k6sz2Gv0AoWUYXjg2M47r-k5SkM |
| medimmune.com. | TXT | 14400 | TXT Record: 01Z7KTebHecIzA4819LxyE4WdjCsnIvvSjEkE6AiEZVEJ8paVfgO3hbmP1Fb2VAOt3Grb14TWp/uR7NgoEasDw== |
| medimmune.com. | TXT | 14400 | TXT Record: MS=ms39797791 |
| medimmune.com. | TXT | 14400 | TXT Record: _globalsign-domain-verification=oXVOv-rw4-Tybc2UBdy2vwo0h3piIp9KDI_YGNAWlh |
| medimmune.com. | TXT | 14400 | TXT Record: adobe-idp-site-verification=47b89729760f6fc12f80ebce680d38cb05f83102594d174d89cecf5187c46c64 |
| medimmune.com. | TXT | 14400 | TXT Record: docusign=4b9bf3ba-48f3-45d5-a6ea-7d0a36571b0d |
| medimmune.com. | TXT | 14400 | TXT Record: docusign=9f1f76e0-8e8d-4328-bdfc-83a633d3105d |
| medimmune.com. | TXT | 14400 | TXT Record: globalsign-domain-verification=g4fk4eEBPwXiyhY-WrLrzlDOmJqc3U8_fYHYVM1s2C |
HtmlToTextCheckTime:2023-05-14 10:08:19
| Skip to navigation Skip to footer Search Menu Search Search Search Close What science can do R&D R&D Our approach Precision medicine Transformative science Data science & AI Digital health Our technologies Next generation therapeutics Publications R&D strategic centres Our therapy areas All therapy areas Oncology BioPharmaceuticals Cardiovascular, Renal and Metabolism Respiratory & Immunology Vaccines and Immune Therapies Rare Disease Pipeline All medicines Our company Our company Our people Our commitment to patients Our leadership Cambridge Gothenburg Gaithersburg Careers Careers website Working with us Inclusion and diversity Investors Investor Relations (Global) Investor Relations (Sweden) Resources Governance Shareholder information Dividend policy Key facts FAQs Debt Investors ADR Programme Media Press Releases Media centre Statements Articles Image library COVID-19 resources Broadcast videos Archive Media contacts Sustainability Sustainability Access to healthcare Environmental |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 23 Dec 2021 06:04:40 GMT Location: https://www.astrazeneca.com/ Content-Length: 0 X-ORACLE-DMS-ECID: e7be0ff8-5560-4cb9-a160-acd3cf816fe5-325943ff X-ORACLE-DMS-RID: 0 HTTP/2 200 content-type: text/html;charset=UTF-8 content-length: 48931 date: Thu, 23 Dec 2021 06:04:41 GMT server: Apache/2.4.51 () Communique/4.2.3 x-frame-options: SAMEORIGIN cache-control: public,max-age=120 accept-ranges: bytes x-mod-pagespeed: 1.11.33.4-0 access-control-allow-origin: https://policy.cookiereports.com x-content-type-options: nosniff cache-control: max-age=0, no-cache vary: Accept-Encoding x-cache: Miss from cloudfront via: 1.1 3aa2aa1b7b816f70e94675c9a63f98d1.cloudfront.net (CloudFront) x-amz-cf-pop: EWR50-C1 x-amz-cf-id: IKlTPh_QBakXOsN0ot4keF6KKMpcsXP0lNc464p-iGdpEyz2mLycuA== |
medimmune.com Whois Information
Domain Name: MEDIMMUNE.COM Registry Domain ID: 1143677_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-06-15T05:12:14Z Creation Date: 1996-06-20T04:00:00Z Registry Expiry Date: 2022-06-19T04:00:00Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.CSCDNS.NET Name Server: DNS2.CSCDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-26T07:25:12Z <<< |